[EN] HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS<br/>[FR] COMPOSÉS HÉTÉROARYLE INHIBANT DES PROTÉINES RAS PORTANT LA MUTATION G12C
申请人:ASTRAZENECA AB
公开号:WO2018206539A1
公开(公告)日:2018-11-15
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
The present invention relates to novel macrocyclic compounds and salts thereof that bind to and/or are inhibitors of serine protease enzymes. The present invention also relates to intermediates of these compounds, pharmaceutical compositions containing these compounds and methods of using the compounds. These compounds are useful as therapeutics for treatment and prevention of a range of disease indications including hyperproliferative disorders, in particular those characterized by tumor metastasis, inflammatory disorders, skin and tissue disorders, cardiovascular disorders, respiratory disorders and viral infections.
METHODS OF USING MACROCYCLIC INHIBITORS OF SERINE PROTEASE ENZYMES
申请人:Marsault Éric
公开号:US20120270769A1
公开(公告)日:2012-10-25
The present invention relates to novel macrocyclic compounds and salts thereof that bind to and/or are inhibitors of serine protease enzymes and methods of using the compounds. The present invention also relates to intermediates of these compounds, pharmaceutical compositions containing these compounds and methods of using the same. These compounds are useful as therapeutics for treatment and prevention of a range of disease indications including hyperproliferative disorders, in particular those characterized by tumor metastasis, inflammatory disorders, skin and tissue disorders, cardiovascular disorders, respiratory disorders and viral infections.
[EN] MACROCYCLES AND THEIR USE<br/>[FR] MACROCYCLES ET LEUR UTILISATION
申请人:BLOSSOMHILL THERAPEUTICS INC
公开号:WO2022133037A1
公开(公告)日:2022-06-23
The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.
本公开涉及大环化合物、含有大环化合物的药物组合物、以及使用大环化合物治疗疾病(如癌症)的方法。
A New Bromination Method for Phenols and Anisoles: NBS/HBF<sub>4</sub>·Et<sub>2</sub>O in CH<sub>3</sub>CN